End-of-day quote
Other stock markets
|
||
- | - |
|
2023 | Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding | CI |
2023 | Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 59,000 | 100.0 % | 68,445 | 100.0 % | +16.01% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 54,237 | 93.4 % | 68,445 | 100.0 % | +26.20% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Seong-Won Oh
CEO | Chief Executive Officer | 46 | - |
Seung-Jae Lim
AUD | Comptroller/Controller/Auditor | 77 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Byung-Jin Kim
BRD | Director/Board Member | 47 | - |
Seong-Won Oh
CEO | Chief Executive Officer | 46 | - |
Hyeon-Bo Yoon
BRD | Director/Board Member | 53 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 35,593,402 | 25,655,158 ( 72.08 %) | 287 ( 0.000806 %) | 72.08 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
KYUNG NAM PHARM CO.,LTD. 0.00% | 287 | 0.00% | 216 $ |
BILLIONS CO.,LTD. -.--% | 0 | -.--% | 0 $ |
Company contact information
Kyungnam Pharm Co., Ltd.
79 Guryong-ro 4nam-gil Uiryeong-eup
52153, Uiryeong-gun
+
http://www.kyungnampharm.co.kr![address Kyung Nam Pharm Co Ltd](https://cdn.zonebourse.com/static/address/20700515.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+25.59% | 45.93B | |
+36.11% | 23.66B | |
+28.60% | 16.25B | |
+20.84% | 14.63B | |
+68.80% | 14.22B | |
-0.05% | 6.79B | |
-11.31% | 6.3B | |
+15.48% | 5.77B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A053950 Stock
- Stock
- Company Kyung Nam Pharm Co Ltd